Coloplast A/S (OTCMKTS:CLPBY) Reaches New 52-Week Low – Time to Sell?

Coloplast A/S Sponsored ADR (OTCMKTS:CLPBY)’s stock price reached a new 52-week low during mid-day trading on Wednesday . The company traded as low as $5.83 and last traded at $5.8350, with a volume of 1228 shares. The stock had previously closed at $5.92.

Analyst Ratings Changes

A number of equities research analysts have weighed in on CLPBY shares. The Goldman Sachs Group downgraded shares of Coloplast A/S from a “hold” rating to a “strong sell” rating in a report on Tuesday, April 7th. Kepler Capital Markets raised Coloplast A/S to a “strong-buy” rating in a research note on Wednesday, May 20th. One analyst has rated the stock with a Strong Buy rating, one has issued a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Hold”.

Coloplast A/S Trading Down 1.5%

The company has a quick ratio of 0.81, a current ratio of 1.30 and a debt-to-equity ratio of 1.50. The firm has a market cap of $13.14 billion, a price-to-earnings ratio of 41.64, a PEG ratio of 1.87 and a beta of 0.18. The company has a 50-day moving average price of $6.34 and a 200 day moving average price of $7.44.

Coloplast A/S (OTCMKTS:CLPBY) last announced its quarterly earnings data on Tuesday, May 12th. The company reported $0.10 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.09 by $0.01. The firm had revenue of $1.11 billion during the quarter, compared to the consensus estimate of $1.11 billion. Coloplast A/S had a return on equity of 31.96% and a net margin of 7.46%. As a group, research analysts anticipate that Coloplast A/S Sponsored ADR will post 0.4 earnings per share for the current fiscal year.

About Coloplast A/S

Coloplast A/S is a global developer and manufacturer of medical devices and services focused on intimate healthcare. The company specializes in solutions designed to assist individuals with chronic medical conditions, aiming to improve quality of life through innovative products. Coloplast’s offerings span ostomy care, continence care, wound and skin care, and interventional urology, targeting patients who require long-term support and specialized treatments.

In its ostomy business, Coloplast provides pouches, skin barriers and accessories for patients who have had surgical procedures to divert bodily waste.